The largest database of trusted experimental protocols

7 protocols using mem amino acid solution

1

Ligamentocyte Isolation and Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
LACL-derived ligamentocytes were harvested from six adult males, healthy 12-month-old ACLs of New Zealand Rabbits, obtained from the regional slaughterhouse. The explanted LACLs were split into 2-mm2 pieces and were cultivated in T25 culture flasks in growth medium (Dulbecco's modified Eagle’s medium [DMEM]/Ham’s F12 medium [1:1, Merck KGaA, Darmstadt, Germany] supplemented with 10% fetal bovine serum [FBS, Merck KGaA], 1% penicillin/streptomycin solution [Merck KGaA], 25 μg/ml ascorbic acid [Sigma-Aldrich, Munich, Germany], 2.5 μg/ml amphotericin B [Merck KGaA], MEM amino acid solution [Sigma-Aldrich]). After 7–10 days, ligamentocytes emigrated and were expanded using 0.05% trypsin/0.02% ethylenediaminetetraacetic acid (EDTA) for the subsequent experiments.
+ Open protocol
+ Expand
2

Overexpression of E. coli mgrB-H6 Fusion Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
A sequence containing the E. coli EDL933 mgrB gene (Genbank Z2872) fused to a C-terminal His-6 tag (Supplementary Fig. 1d) was designed, synthesised (Eurofins), and subcloned into the XbaI and XhoI restriction sites of pBluescript KS(-) to obtain plasmid pmgrB-H6. This is the mgrB sequence of the first EHEC isolate sequenced (strain EDL933)81 (link) which is identical to the ones found in BL21 or K12. The plasmid was then transformed into E. coli TOP10 cells to isolate sufficient amounts of plasmid DNA and verify the sequence. For overexpression, pmgrB-H6 was transfected into E. coli BL21 (DE3) pLysS (NEB) and plated on ampicillin-containing agar plates (100 µg/ml). In all, 16–24 h later, freshly grown colonies were transferred to 30 ml 1x M9 Salt Solution (Sigma-Aldrich) supplemented with 1x MEM Amino Acid Solution (Sigma-Aldrich). After 24–48 h, this bacterial culture was harvested by centrifugation and resuspended in M9 medium supplemented with the amino acid mix and 0.1 mM IPTG (Sigma-Aldrich). After different time points, 10 ml samples were collected, the bacteria were harvested by centrifugation and the supernatant was sterile filtrated using 0.2 µM filters (Filtropur S, Sarsted). All samples were immediately frozen and stored at −20 °C until use.
+ Open protocol
+ Expand
3

Isolation and Culture of Rabbit ACL Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
LACL-derived fibroblasts were isolated from 7 female, healthy ACLs of New Zealand Rabbits (approximate 12 months) derived from the abattoir. Explanted LACLs were sliced into 2 mm2 pieces and placed into a T25 culture flask with growth medium for several weeks (Dulbecco’s Modified Eagle´s Medium (DMEM)/Ham’s F12 medium (1:1, Merck KGaA, Darmstadt, Germany) supplemented with 10% fetal bovine serum (FBS, Merck KGaA), 1% penicillin/streptomycin solution (Merck KGaA), 25 μg/mL ascorbic acid (Sigma-Aldrich, Munich, Germany), 2.5 μg/mL amphotericin B (Merck KGaA), MEM amino acid solution (Sigma-Aldrich). After 7–10 days, emigrating cells could be harvested using 0.05% trypsin/0.02% EDTA treatment and be further expanded.
+ Open protocol
+ Expand
4

Isolation of Lapine Cruciate Ligamentocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lapine cruciate ligaments used for cell isolation were obtained from the abattoir. Lapine cruciate ligamentocytes were isolated from four healthy female and one male New Zealand Rabbits (mean age of 12 months). Surrounding connective tissue was removed and 1–2-mm sized pieces of the cruciate ligaments were prepared and transferred into a T-25 culture flask (Sarstedt AG & Co. KG, Nürnbrecht, Germany) with 2 mL culture medium (Dulbecco’s Modified Eagle’s Medium (DMEM)/Ham’s F12 medium [1:1] (Bio&SELL), containing 10% fetal bovine serum (FBS, Bio&SELL), 1% penicillin/streptomycin solution, 25 μg/mL ascorbic acid (Sigma-Aldrich, Munich, Germany), 2.5 μg/mL amphotericin B (Bio&SELL) and MEM amino acid solution (Sigma-Aldrich)). Culture medium was changed every 2–3 days. After around 1 week, cruciate ligamentocytes emigrated from the explant. Cells were detached after being 80% confluent using 0.05% trypsin/0.02% ethylenediaminetetraacetic acid (EDTA) solution (Bio&SELL). Cell numbers and viability were calculated with a hemocytometer using the trypan blue exclusion assay.
+ Open protocol
+ Expand
5

Isolation and Culture of Rabbit Cruciate Ligamentocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
For isolation of lapine cruciate ligamentocytes anteroir (ACLs) and posterior cruciate ligaments (PCLs) of 10 healthy male and female New Zealand rabbits (between 4 and 24 months old) obtained from the abattoir were harvested. Slices of 1–2 mm of the ACLs and PCLs (Cls) were prepared and transferred into T25 culture flasks (Sarstedt AG & Co. KG, Nürnbrecht, Germany) with growth medium (Dulbecco’s Modified Eagle’s Medium (DMEM)/Ham’s F12 medium (1:1) (Bio&SELL, Feucht, Germany), containing 10% fetal bovine serum (FBS, Bio&SELL), 1% penicillin/streptomycin solution, 25 μg/mL ascorbic acid (Sigma-Aldrich, Munich, Germany), 2.5 μg/mL amphotericin B (Bio&SELL) and MEM amino acid solution (Sigma-Aldrich)).
Growth medium was changed 2–3 times a week. After 7–10 days, CL-derived ligamentocytes emigrated and were detached using 0.05% trypsin/ 0.02% ethylenediaminetetraacetic acid (EDTA) solution (Bio&SELL). The number of viable cells was determined using the trypan blue exclusion assay with a hemocytometer.
+ Open protocol
+ Expand
6

Isolation and Expansion of Ligamentocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The lACL-derived ligamentocytes were harvested from five adult males, healthy 12-month-old ACLs of New Zealand Rabbits, obtained from the regional slaughterhouse. The explanted LACLs were split into 2 mm2 pieces and were cultivated in T25 culture flasks in ligamentocyte growth medium (Dulbecco’s Modified Eagle’s Medium [DMEM]/Ham’s F12 medium [1:1, PAN-Biotech] supplemented with 10% fetal bovine serum [FBS, PAN-Biotech], 1% penicillin/streptomycin solution [PAN-Biotech], 25 μg/mL ascorbic acid [Sigma-Aldrich, Munich, Germany], 2.5 μg/mL amphotericin B [PAN-Biotech] and MEM amino acid solution [Sigma-Aldrich]). After 7–10 days, ligamentocytes emigrated and were expanded using 0.05% trypsin/0.02% ethylenediaminetetraacetic acid (EDTA, PAN-Biotech) for the subsequent experiments.
+ Open protocol
+ Expand
7

Cytotoxicity of Silver Nanoparticles in HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human hepatocellular carcinoma (HepG2) cells (ATCC#HB-8065) were used to determine the cytotoxicity of AgNPs as in [44 (link)]. Briefly HepG2 cells were maintained in minimum essential medium (MEM, Gibco) enriched with 10 % fetal bovine serum (FBS), 1 mM sodium pyruvate (Gibco, Carlsbad, CA, USA), 1× MEM amino acid solution (Sigma-Aldrich), 100 IU mL Penicillin, and 100 mg streptomycin (Cellgro Inc., Herndon, VA). At confluence monolayer-adhered cells were detached and dispersed using 1× Trypsin/EDTA solution (Gibco, Carlsbad, CA, USA). 5 × 105 cells/mL were added 100 µL to each well of the 96-well microtiter plates containing 100 µL of serial two-fold dilutions of the AgNPs. The 96 well plates were incubated for 24 h at 37 °C with CO2, and the cytotoxicity was determined using the PrestoBlue cell viability assay [45 (link)]. From these data, the CC50 value, defined as the concentration of AgNPs leading to 50 % inhibition. All experiments were performed in duplicate and were repeated for three times. The CC50 was assessed from the dose–response curves determined by fitting the data using Origin 8 (OriginLab Corp., Northampton, MA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!